CONCENTRIX CORP's ticker is CNXC and the CUSIP is 20602D101. A total of 304 filers reported holding CONCENTRIX CORP in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $223,468 | -79.0% | 3,532 | -78.0% | 0.00% | – |
| Q1 2024 | $1,062,129 | -35.4% | 16,040 | -4.2% | 0.00% | – |
| Q4 2023 | $1,644,912 | +19.3% | 16,750 | -2.7% | 0.00% | – |
| Q3 2023 | $1,378,447 | +6.5% | 17,208 | +7.3% | 0.00% | – |
| Q2 2023 | $1,294,725 | +160.4% | 16,034 | +292.1% | 0.00% | – |
| Q1 2023 | $497,166 | -15.7% | 4,089 | -7.6% | 0.00% | – |
| Q4 2022 | $589,461 | +24.4% | 4,427 | +4.3% | 0.00% | – |
| Q3 2022 | $474,000 | -7.2% | 4,243 | +12.7% | 0.00% | – |
| Q2 2022 | $511,000 | -95.1% | 3,765 | -94.0% | 0.00% | -100.0% |
| Q1 2022 | $10,504,000 | +29.3% | 63,061 | +38.7% | 0.00% | +50.0% |
| Q4 2021 | $8,122,000 | -90.8% | 45,475 | -90.9% | 0.00% | -89.5% |
| Q3 2021 | $88,227,000 | +3.3% | 498,461 | -6.1% | 0.02% | 0.0% |
| Q2 2021 | $85,399,000 | +21.7% | 531,093 | +13.3% | 0.02% | +18.8% |
| Q1 2021 | $70,176,000 | +91.2% | 468,725 | +26.0% | 0.02% | +77.8% |
| Q4 2020 | $36,707,000 | – | 371,901 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Groupe Bruxelles Lambert | 8,773,667 | $555,197,648 | 100.00% |
| Impactive Capital LP | 3,846,370 | $243,398,294 | 9.46% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 623,542 | $39,457,738 | 1.80% |
| LYRICAL ASSET MANAGEMENT LP | 1,271,250 | $80,444,700 | 1.29% |
| Copeland Capital Management, LLC | 985,722 | $62,376,533 | 1.17% |
| Nierenberg Investment Management Company, Inc. | 27,910 | $1,766,145 | 0.99% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 564,732 | $35,736,207 | 0.97% |
| VALLEY WEALTH MANAGERS, INC. | 168,482 | $10,661,541 | 0.85% |
| Bragg Financial Advisors, Inc | 202,698 | $12,826,730 | 0.57% |
| CLARK ESTATES INC/NY | 44,250 | $2,800,140 | 0.53% |